Novel indomethacin action: Selective and direct activation of protein kinase C-ε

Cellular Physiology and Biochemistry

Volumn 30, Issue 3, 2012, Pages 771-777

  Kanno, Takeshi ^a   Tsuchiya, Ayako ^a   Shimizu, Tadashi ^a   Tanaka, Akito ^a   Nishizaki, Tomoyuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Direct binding; Indomethacin; Protein kinase C ; Selective activation

Indexed keywords

CALCIUM; DIACYLGLYCEROL; FLUORESCEIN; INDOMETACIN; PHOSPHATIDYLSERINE; PROTEIN KINASE C EPSILON; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; FLUORESCENCE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

EID: 84864414622     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000341456     Document Type: Article

References (15)

1. Etminan M, Gill S, Samii A: Effect of nonsteroidal anti-inflammatory drugs on risk of Alzheimers disease: systematic review and meta-analysis of observational studies. Br Med J 2003;327:128.
2. Int Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, Breteler MM, Stricker B: Nonsteroidal antiinflammatory drugs and the risk of Alzheimers disease. N Eng J Med 2001;345:1515-1521.
3. Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN: Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimers disease: a systematic review. Neuroepidemiology 2004;23:159-169.
4. Townsend KP, Praticò D: Novel therapeutic opportunities for Alzheimers disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J 2005;19:1592-1601.
5. Kanno T, Yaguchi T, Nagata T, Shimizu T, Tanaka A, Nishizaki T: Indomethacin enhances learning and memory potential by interacting with CaMKII. J Cell Physiol 2012;227:919-926.
6. Kanno T, Yaguchi T, Nagata T, Nishizaki T: Indomethacin activates protein kinase C and potentiates a7 ACh receptor responses. Cell Physiol Biochem 2012;2012;29:189-196.
7. Shimizu T, Kanno T, Tanaka A, Nishizaki, T: a, ß-DCP-LA selectively activates PKC-s and stimulates neurotransmitter release with the highest potency among 4 diastereomers. Cell Physiol Biochem 2011;27:149-158.
8. Isakov N: Activation of murine lymphocytes by exogenous phosphatidylethanolamine-and phosphatidylcholine-specific phospholipase C. Cell Immunol 1993;152:72-81.
9. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-614.
10. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484-496.
11. Shirai Y, Adachi N, Saito N: Protein kinase Cs: function in neurons. FEBS J 2008;275:3988-3994.
12. Nishizaki T, Nomura T, Matsuyama S, Kondoh T, Fujimoto E, Yoshii M: Critical role of presynaptic nicotinic ACh receptor in the formation of long-term potentiation: implication of development of anti-dementia drug. Psychogeriatrics 2001;1:209-217.
13. Yamamoto S, Kanno T, Nagata T, Yaguchi T, Tanaka A, Nishizaki T: The linoleic acid derivative FR236924 facilitates hippocampal synaptic transmission by enhancing activity of presynaptic a7 acetylcholine receptors on the glutamatergic terminals. Neuroscience 2005;130:207-213.
14. Kanno T, Yaguchi T, Yamamoto S, Nagata T, Yamamoto H, Fujikawa H, Nishizaki T: Bidirectional regulations for glutamate and GABA release in the hippocampus by a7 and non-a7 ACh receptors. Biochem Biophys Res Commun 2005;338:742-747.
15. Kanno T, Yaguchi T, Yamamoto S, Yamamoto H, Fujikawa H, Nagata T, Tanaka A, Nishizaki T: 8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid stimulates GABA release from interneurons projecting to CA1 pyramidal neurons in the rat hippocampus via pre-synaptic a7 acetylcholine receptors. J Neurochem 2005;95:695-702.